PACIFIC BIOSCIENCES

Pacific Biosciences designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Its single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes. Pacific Biosciences offers PacBio RS II and Sequel Systems that conducts, monitors, and analyzes single molecule biochemical reactions in real time. It also provides consumable products, including SMRT cells, as well as various reagent kits, such as temp... late preparation, binding, and sequencing kits. Pacific Biosciences' customers include research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as primarily through distribution partners in Asia, the Middle East, and Latin America. Joseph Bonventre and Stephen Turner founded Nanofluidics in 2000 that laterbecame Pacific Biosciences. Its headquarters is in Menlo Park in California.
PACIFIC BIOSCIENCES
Industry:
Biotechnology Genetics Industrial Life Science Medical
Founded:
2004-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.pacb.com
Total Employee:
251+
Status:
Active
Contact:
(650)618-2699
Email Addresses:
[email protected]
Total Funding:
1.26 B USD
Technology used in webpage:
SPF SSL By Default LetsEncrypt Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS Facebook Pixel Cloudflare DNS GoDaddy
Similar Organizations
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2021-08-03 | Circulomics | Circulomics acquired by Pacific Biosciences | N/A |
2021-07-20 | Omniome | Omniome acquired by Pacific Biosciences | 800 M USD |
Investors List
SoftBank
SoftBank investment in Post-IPO Debt - Pacific Biosciences
Deerfield
Deerfield investment in Post-IPO Debt - Pacific Biosciences
Intel Capital
Intel Capital investment in Series F - Pacific Biosciences
AllianceBernstein
AllianceBernstein investment in Series F - Pacific Biosciences
Morgan Stanley
Morgan Stanley investment in Series F - Pacific Biosciences
Maverick Ventures
Maverick Ventures investment in Series F - Pacific Biosciences
DAG Ventures
DAG Ventures investment in Series F - Pacific Biosciences
Kleiner Perkins
Kleiner Perkins investment in Series F - Pacific Biosciences
Alloy Ventures
Alloy Ventures investment in Series F - Pacific Biosciences
Gen-Probe
Gen-Probe investment in Series F - Pacific Biosciences
Newest Events participated

Key Employee Changes
Date | New article |
---|---|
2020-09-14 | Pacific Biosciences appoints Susan Kim as CFO |
2020-08-07 | Pacific Biosciences Announces New Chief Executive Officer |
Official Site Inspections
http://www.pacb.com Semrush global rank: 787.73 K Semrush visits lastest month: 50.02 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Pacific Biosciences"
Pacific Biosciences - Wikipedia
Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some …See details»
PacBio Announces Preliminary First Quarter 2025 Revenue and …
3 days ago Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, …See details»
PacBio - Crunchbase Company Profile & Funding
PacBio designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Its single molecule real-time (SMRT) sequencing technology enables single …See details»
PacBio Announces Preliminary First Quarter 2025 Revenue and …
3 days ago MENLO PARK, Calif., April 09, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced preliminary, unaudited revenue for the quarter ended March 31, …See details»
Pacific Biosciences CCO departs amid restructuring - Investing.com
Nov 12, 2024 Despite these challenges, PACB has shown strong recent stock performance, with InvestingPro data indicating a 72.03% price total return over the last three months.See details»
PacBio Announces Preliminary First Quarter 2025 ... - Markets Insider
3 days ago MENLO PARK, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced preliminary, unaudited revenue for the quarter ended March 31, …See details»
Pacific Biosciences of California, Inc. (PACB) - Yahoo Finance
See the company profile for Pacific Biosciences of California, Inc. (PACB) including business summary, industry/sector information, number of employees, business summary, corporate …See details»
PacBio Announces Preliminary Fourth Quarter and Full Year Revenue
MENLO PARK, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced …See details»
PacBio Announces Appointment of Chris Smith to Board of Directors
Jan 30, 2025 PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and …See details»
Patient Advocate Certification Board, Inc. (PACB) | LinkedIn
Accordingly, PACB’s publicly released documents are the product of countless hours of volunteer work by a diverse group of PACB members, task force members, practitioners, educators and ...See details»
PacBio Announces Preliminary First Quarter 2025 Revenue and …
3 days ago PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and …See details»
PacBio Announces Fourth Quarter and Fiscal Year 2024 Financial …
MENLO PARK, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2024. Fourth …See details»
PacBio PAG 2025 - programs.pacb.com
Organization. Country State. Main field of interest. Area(s) of interest Plant + animal research Plant + animal microbes Biodiversity Agrigenomics. I want to: Book a meeting at PAG Receive …See details»
Pacific Biosciences of California, Inc. (PACB)
Find the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Organization | Cystic Fibrosis Translational Research Centre …
PACB is committed to providing top-quality airway epithelial cells to researchers. This platform involves the establishment of a procurement network through Canada, with several physicians …See details»
Sustainability - PacBio
Therefore, we are embarking on a journey to unlock the transformational capabilities of ESG within our organization and embed them into our long-term business strategy. We aim to make …See details»
Pacific Biosciences (PACB) Receives a Hold from Morgan Stanley
Jan 13, 2025 Pacific Biosciences (PACB) Company Description: Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform …See details»
Pacific Biosciences of California, Inc. (PACB) - Yahoo Finance Canada
See the company profile for Pacific Biosciences of California, Inc. (PACB) including business summary, industry/sector information, number of employees, business summary, corporate …See details»
[[Organization]] | [[City, State]] | [[Organization]] | [[City, State]]
Copyright © 2012 Pennsylvania Association of Community Bankers. All rights reserved. 800 N. Third Street, Suite 304, Harrisburg, PA 17102 Phone: 717-231-7447 | Fax:See details»
PacBio Announces Preliminary First Quarter 2025 Revenue and …
Apr. 09, 2025 9:05 AM ET Pacific Biosciences of California, Inc. (PACB) Implements Plan to Reduce Annualized Operating Expense Run Rate by $45 Million to $50 Million Q1 2025 …See details»